| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |